Percutaneous Cryoablation Peripheral Lung Cancer (PCPLC)

Shanghai Jiao Tong University

Status: Unknown

Conditions: Lung Cancer

Treatments: Procedure: Percutaneous cryoablation

Study type: Interventional

Funder types: Other

Identifiers

NCT02665390

SHCHE201601

Details and patient eligibility

About

This study is focus on percutaneous cryoablation,which was for the treatment of medically inoperable Peripheral lung cancer.The patients who were agreed to attend the study will accept the operation. After the operations,they will follow up according to the plan.

Full description

The patients who were agreed to attend the study conclude early stage lung cancer and solitary metastatic lung cancer.

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

medically inoperable peripheral lung cancer Diameter no more than 3cm

Exclusion criteria

1. Refusal of participation
2. tendency to bleed to that can't receive percutaneous cryoablation.
3. Severe cardiopulmonary dysfunction and other indications that can't receive percutaneous cryoablation.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

treatment

Experimental group

Description:

Patients who are medically inoperable peripheral lung cancer will enroll in this study.They will receive percutaneous cryoablation and follow-up according to schedule.

Treatment:

Procedure: Percutaneous cryoablation